Macrogenics (MGNX) Operating Leases (2012 - 2026)

Macrogenics (MGNX) has 13 years of Operating Leases data on file, last reported at $31.3 million in Q1 2026.

• On a quarterly basis, Operating Leases fell 2.5% year-over-year to $31.3 million in Q1 2026; TTM through Mar 2026 was $31.3 million, a 2.5% decrease from a year earlier, with the FY2025 full-year figure at $31.6 million, down 3.1% from the prior year.
• Operating Leases for Q1 2026 stood at $31.3 million, down from $31.6 million in the prior quarter.
• Over the last five years, Operating Leases for MGNX reached as high as $32.6 million in Q4 2024 and fell as low as $17.0 million in Q3 2022.
• Historically, Operating Leases has averaged $28.6 million across 5 years, with a median of $30.2 million in 2023.
• Across the five-year window, Operating Leases retreated 22.81% in 2022 and surged 77.54% in 2023, its largest moves.
• Year by year, Operating Leases stood at $30.1 million in 2022, then advanced by 0.3% to $30.2 million in 2023, then gained by 7.95% to $32.6 million in 2024, then dropped by 3.1% to $31.6 million in 2025, then fell by 0.92% to $31.3 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $31.3 million in Q1 2026, $31.6 million in Q4 2025, and $31.9 million in Q3 2025.